Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Operating Expenses | 3,247 | 2,253 | 3,594 | 4,285 | 4,205 |
| Operating Income | -3,247 | -2,253 | -3,594 | -4,285 | -4,205 |
| Other Income | -924 | 332 | 1,247 | 453 | -263 |
| Pre-tax Income | -4,170 | -1,921 | -2,347 | -3,833 | -4,468 |
| Net Income Continuous | -4,170 | -1,921 | -2,347 | -3,833 | -4,468 |
| Net Income | $-4,170 | $-1,921 | $-2,347 | $-3,833 | $-4,468 |
| EPS Basic Total Ops | -0.04 | -0.02 | -0.02 | -0.03 | -0.04 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.02 | -0.03 | -0.04 |
| EPS Diluted Total Ops | -0.04 | -0.02 | -0.02 | -0.03 | -0.04 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.02 | -0.03 | -0.04 |
| EBITDA(a) | $-3,077 | $-2,084 | $-3,425 | $-4,116 | $-4,036 |